---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-021084"
form_type: "8-K"
ticker: "EXOZ"
cik: "0002010788"
company_name: "EXOZYMES INC."
filed_at: "2025-07-28T23:59:59+00:00"
generated_at: "2026-05-18T00:30:29.364562+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# eXoZymes shareholders elect all six director nominees, approve compensation and 2025 equity plan at annual meeting

## Summary
- All six director nominees (Marlett, DiGiandomenico, Bowie, Lalonde, Bell, Rayo) elected with at least 4.25M votes for.
- Non-binding advisory resolution on executive compensation approved: 4,272,987 for, 1,801 against.
- Shareholders voted for a three-year frequency of future advisory votes on executive compensation (4,121,899 for three years).
- 2025 Performance Equity Plan approved: 4,181,189 for, 92,840 against.
- Ratification of RBSM LLP as auditor for FY2025 received 4,779,589 votes for; quorum was 56.98%.

## SEC filing metadata
- accession: 0001641172-25-021084
- form_type: 8-K
- ticker: EXOZ
- cik: 0002010788
- company_name: EXOZYMES INC.
- filed_at: 2025-07-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2010788/000164117225021084/0001641172-25-021084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2010788/000164117225021084/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-021084
- JSON: https://secwatch.observer/filing/0001641172-25-021084.json
- Plain text: https://secwatch.observer/filing/0001641172-25-021084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.